Cargando…
Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
In patients with differentiated thyroid cancer, stimulated thyroglobulin (sTg) levels after thyroid hormone withdrawal (THW) at remnant ablation (RA) and at 6 to 12 months are known to have good prognostic value. This study aimed to evaluate the prognostic impacts and best cutoff values of sTg level...
Autores principales: | Ha, Jeonghoon, Kim, Min Hee, Jo, Kwanhoon, Lim, Yejee, Bae, Ja Seong, Lee, Sohee, Kang, Moo Il, Cha, Bong Yun, Lim, Dong Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521902/ https://www.ncbi.nlm.nih.gov/pubmed/28723762 http://dx.doi.org/10.1097/MD.0000000000007512 |
Ejemplares similares
-
Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
por: Jeong, Eugene, et al.
Publicado: (2019) -
Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015) -
Assessment of three different radioiodine doses for ablation therapy of thyroid remnants: Efficiency, complications and patient comfort
por: Soyluoglu, Selin, et al.
Publicado: (2023) -
Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake
por: Wang, Zhaojun, et al.
Publicado: (2016) -
The relationship between papillary thyroid carcinoma and preoperative TSH level: A cross-sectional study from Syria
por: Shahrokh, Marjan, et al.
Publicado: (2023)